Stereotaxis to acquire Robocath for $20M

Stereotaxis has entered into an agreement to acquire Robocath for an upfront payment of $20 million. This strategic acquisition is expected to enhance Stereotaxis's capabilities and expand its market presence in the medical technology sector. The deal signifies a move towards consolidation and growth within the industry, aiming to leverage combined expertise and technologies to drive innovation and improve patient outcomes.